Related Experiment Video
Updated: Apr 27, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Remnant cholesterol and ischemic heart disease
Anette Varbo1, Børge G Nordestgaard
1aDepartment of Clinical Biochemistry bThe Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital cFaculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Elevated remnant cholesterol, found in triglyceride-rich lipoproteins, is increasingly recognized as a causal risk factor for ischemic heart disease (IHD). This finding helps explain residual IHD risk even after lowering LDL-cholesterol.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Atherosclerosis Research
Background:
- Remnant cholesterol, present in triglyceride-rich lipoproteins, is implicated in cardiovascular disease.
- Understanding its role is crucial for managing ischemic heart disease (IHD).
Purpose of the Study:
- To review recent scientific advances on remnant cholesterol's contribution to IHD.
- To evaluate the evidence supporting remnant cholesterol as an independent risk factor.
Main Methods:
- Review of epidemiologic, mechanistic, and genetic studies.
- Analysis of observational data linking remnant cholesterol to IHD.
- Examination of genetic evidence for causality.
Main Results:
- Epidemiologic and genetic studies confirm remnant cholesterol as a contributor to atherosclerosis and IHD.
- Mechanistic studies show remnant cholesterol accumulation in arterial walls, similar to LDL-cholesterol.
- Genetic data suggests remnant cholesterol is a causal risk factor, independent of HDL-cholesterol, and linked to inflammation.
Conclusions:
- Emerging evidence strongly suggests elevated remnant cholesterol is a causal risk factor for IHD.
- It may explain residual IHD risk in patients with optimized LDL-cholesterol levels.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Inflammation
Coronary Artery Disease II: Pathophysiology
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis I: Introduction
Atherosclerosis III: Management